Submit or Track your Manuscript LOG-IN

Protective Effect of Laurus nobilis Extract against Hypercholesterolemia Damage in Male Rats

PJZ_55_4_1613-1619

Protective Effect of Laurus nobilis Extract against Hypercholesterolemia Damage in Male Rats

Amr N. El-Shahat1*, A.M. Abdul Azeem1 and Mohamed H.M. Abd el Megid2

1Food Irradiation Research Department, Egyptian Atomic Energy Authority, 3 Ahmed El-Zomor St., El-Zohour District, 8th District, Nasr City, Cairo

2Natural Products Department, Egyptian Atomic Energy Authority, 3 Ahmed El-Zomor St., El-Zohour District, 8th District, Nasr City, Cairo

ABSTRACT

Laurus nobilis (Bay leaf) has been shown to possess various biological activities such as antioxidant activity, anti-inflammatory activity and prevention of cardiovascular diseases. The present study aims to investigate the effectiveness of bay leaf extract (BLE) in protection against high cholesterol diet (HCD) induced hypercholesterolemia. About thirteen compounds of essential oils were identified by GC/MS analysis including 1.8-cineole, Linalool and sabinene which represent the main volatile oils of bay leaf. Supplementation of BLE with HCD for 10 weeks resulted in reduction in the levels of some lipid contents (total cholesterol, triglycerides, Low-density lipoprotein-cholesterol and very Low-density lipoprotein-cholesterol), tumor necrotic factor-alpha and interleukin-6 as well as reduced activity of hepatic and cardiac enzymes. Also, feeding rats on HCD with BLE enhance the antioxidant status in liver and heart tissues with indicated inhibition of lipid peroxidation by reducing the level of malondialdehyde compared to HCD-fed rats. The results concluded that BLE may have an effective role in reducing high cholesterol levels.


Article Information

Received 28 August 2021

Revised 05 April 2022

Accepted 21 April 2022

Available online 10 June 2022

(early access)

Published 05 June 2023

Authors’ Contribution

ANE performed animal experiments. ANAA and MHMAM performed the biological study and collected blood samples. ANE, ANAA and MHMAM wrote the manuscript

Key words

Laurus nobilis, High cholesterol diet, Tumor necrotic factor-alpha, Interleukin-6, Antioxidant activity

DOI: https://dx.doi.org/10.17582/journal.pjz/20210828210818

* Corresponding author: amrshahat22@yahoo.com

0030-9923/2023/0004-1613 $ 9.00/0

Copyright 2023 by the authors. Licensee Zoological Society of Pakistan.

This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).



Introduction

Hypercholesterolemia is understood as elevation of total cholesterol levels within the blood which may have occurred as a result of inherited diseases, obesity, unbalanced diet or different diseases like diabetes (Makkos et al., 2020). It is one among metabolic disorders that plays an important role within the occurrence of atherosclerosis and may be a risk factor for coronary heart diseases (Pluijmert et al., 2019). Hypercholesterolemia can impair left ventricular (LV) function by decreasing coronary blood flow reserve and capillary density with induction of apoptosis (Yao et al., 2020). Additionally, hypercholesterolemia induces oxidative and nitrative stress that plays a role in several cardiac disfunction (Pluijmert et al., 2019). Therefore, modulation of hypercholesterolemia appears to be mandatory approach to avoid hypercholesterolemic myocardium complications (Csonka et al., 2016) but there are some of unexpected side effects could be occurred due to using of anti-cholesterol chemical drugs in a long-term (Hartanti et al., 2019). Thus, there is an obvious need for more efficacious and alternative treatment options such as using of herbal plants that contain different components characterised by their pharmacological effectiveness without any complications.

Laurus nobilis (Bay leaf) is an aromatic herb that belonging to the Lauraceae family and widely used as a condiment and spice (Mohammed et al., 2021). The tea of bay leaves is used traditionally as a therapy against diarrhea, for rheumatic pains and treatment of asthma, and cardiac diseases (Mohammed et al., 2021). This herbal plant possesses several types of metabolites that characterized by their antioxidant properties, anti-inflammatory actions, inhibition of oxidative enzymes (Hartanti et al., 2019).Also, the bioactive components in bay leaves such as saponin, terpenoid, flavonoid, polyphenol, alkaloid, and essential oil have been shown to have effects on insulin sensitivity and can lower cholesterol levels by inhibiting the action of HMG-CoA Reductase (Hartanti et al., 2019).Therefore, this study aims to investigate the possible hypocholesterolaemic effect of Laurus nobilis leave extract in male rats fed a high-cholesterol diet (HCD) to avoid the side effects induced by anti-cholesterol chemical drugs.

MaterialS and Methods

All experiments were carried out during 2021 at the Egyptian atomic energy authority, food irradiation department. Chemicals and reagents were purchased from Sigma Chemical Co. (St. Louis, MO, USA).

Essential oil components of Laurus nobilis

Fresh Bay leaf leaves (Laurus nobilis) were purchased from local market (Cairo, Egypt). Separation and identification of essential oil components were performed by using Gas chromatography instrument, Model Hewlett-Packard- MS (5970) series II Condition analysis as follow: Column: 30m hp Methyl silicon 0.1mm; Temperature: Initial 60 ºC; Rate: 3 ºC/ min up to 240 ºC; Carrier gas: Helium 1.0 ml/min; Injection port; Temperature: 250 ºC; Detector temperature: 270ºC; Integration: By using HP software Data; Injection volume: 0.3ml. The isolated peaks were identified by matching with data from the library of mass spectra and compared to those of authentic compounds and published data (Adams, 1995). Quantitative determination was carried out based on peak area integration.

Preparation of Bay leaves extract (BLE)

Bay leaves (BL) were cleaned, washed and dried at room temperature. Then, leaves were grounded for 2 min by electrical grinder.20 g of the leaves were soaked in 200 mL distilled water and was heated at 70 °C in 10 min. by a heater-stirrer (500 r/min). Finally, all the plant residues were removed by filtration and centrifugation of the extract.

Experimental animal

Male albino rats Sprague Dawley (170 to 200g body weight (B. wt.)) were purchased from the Egyptian Holding Company for Biological Products and Vaccines (Cairo, Egypt) and used for the different investigations carried out in the present study. Rats were acclimated to controlled laboratory conditions for two weeks. Rats were maintained on rodent diet and tap water ad libitum. All animals’ procedures were carried out in accordance with the Ethics Committee of the National Research Centre conformed to the Guide for the Care and Use of Laboratory Animals, published by the US National Institutes of Health (NIH Publication No. 85-23, 1996). The high-cholesterol diet (HCD) contained 100 g cholesterol, 30 g propyl thio-uracil, and 100 g cholic acid in 1 L of peanut oil (Inoue et al., 1990).

Experimental design

The study was performed on the adult male rats divided in four groups, each of 7 rats: Group 1 (Control group): was rats fed with normal pellet diet for 10 weeks, group 2 (HCD group): was fed with HCD for 10 weeks, group 3 (BLE group): was given 200 mg kg−1 of BLE (Mohammed et al.,2021) that administered every day orally using intragastric tube for 10th weeks during the examination and group 4 (HCD and BLE): was fed with HCD plus BLE (200 mg/kg B.wt./day/10 weeks) by using intragastric tube.

At the end of 10th week, rats were fasted for 24 h and anaesthetized with diethyl ether. Blood samples were collected through heart puncture and allowed to coagulate and centrifuged for to obtain serum for biochemical analysis. Also, liver and heart tissues were removed for biochemical investigation.

Biochemical analysis

Total cholesterol (TC), triglycerides (TG) and high-density lipoprotein-cholesterol (HDL-C) were determined according to procedure described by Allain et al. (1974), Fossati and Prencipe (1982) and Demacker et al. (1980), respectively. Low-density lipoprotein-cholesterol and very low-density lipoprotein-cholesterol were evaluated according to Friedwald’s formula (Friedwald et al., 1972) by the following equations: LDL-C (mg/dl) = TC-(TG/5+HDL-C), vLDL (mg/dl) = TG/5. The levels of lactate dehydrogenase (LDH) and creatine phosphokinase (CPK) were determined by the method of King (1965). Creatinine kinase-MB (CK-MB) and cardiac troponin I (cTnI) were performed by ELISA technique (BioSource International, Camarillo, CA, USA) according to the manufacturer’s instructions. The activity of serum aspartate transaminase (AST) and alanine transaminase (ALT) was estimated according to Reitman and Frankel (1957), serum γ-glutamyl transferase (GGT) was assessed according to Rosalki (1975) and serum alkaline phosphatase activity (ALP) was assessed according to Kind and King (1954). Detection of serum tumour necrotic factor-alpha (TNF-α) and interleukin-6 (IL-6) was performed by ELISA technique (BioSource International, Camarillo, CA, USA) according to the manufacturer’s instructions.

Hepatic and cardiac tissues (100 mg tissue/ml buffer) were homogenized in 50 mM phosphate buffer (pH 7.2; St. Louis, MO, USA); the homogenates were then centrifuged at 1,200 x g for 15 min and the supernatant was used for determination of the concentration of malondialdehyde (MDA)was according to Yoshioka et al. (1979), GSH content by Beutler et al. (1963), superoxide dismutase activity (SOD) by the method of Minami and Yoshikawa (1979) and catalase activity (CAT) by Johansson and Borg (1988).

Statistical analysis

Results were presented as mean ± SE (n= 6). Experimental data were analysed using one way analysis of variance (ANOVA). Duncan’s multiple range test was used to determine significant differences between means. Data were statistically analysed by the aid of Statistical Package of the Social Sciences, SPSS version 25 (copyrighted by IBM SPSS software, USA). Differences between means were considered significant at P < 0.05.

Results

Table I shows the essential oil contents extracted from bay leaves. 1.8-cineole represents the main volatile oil with value 36.42g/100 g, followed by Linalool 15.17 g/100 g and sabinene 9.39 g/100 g.

As shown in the results under the influence of HCD a significant increase was observed in the level of lipid profile contents (TC, TG, LDL-C, vLDL-C), inflammatory factors (TNF-α and IL-6), liver and cardiac markers (ALP, γGT, ALT, AST, LDH, CK-MB and cTnI) and the level of hepatic and cardiac MDA accompanied by reduction in the level of HDL-C, GSH and the activity of SOD and CAT compared to control group (Tables II, III).

Supplementation of HCD-rats with BLE caused significant reduction in the levels of TC, TG, LDL-C, vLDL-C, TNF-α, IL-6, ALP, γGT, ALT, AST, LDH, CK-MB, cTnI and MDA associated with significant elevation in the level of HDL-C, GSH and the activity of antioxidant enzymes (SOD and CAT) compared to rats fed with HCD.

 

Table I. Essential oil contents extracted from Laurus nobilis.

S. No

Compound

Rt. (min)

g/100 g

1

α-Thujene

15.38

0.37

2

α-Pinene

15.48

3.11

3

Sabinene

16.17

9.39

4

β -Pinene

16.20

2.86

5

β -Myrcene

16.50

1.24

6

1.8-Cineole

17.13

36.42

7

γ-Terpinene

17.60

0.61

8

α -Terpinolene

18.10

0.26

9

β -Terpineol

18.32

0.32

10

Linalool

18.37

15.17

11

Terpinen-4-ol

19.60

1.03

12

α - Terpinyl acetate

22.48

10.05

13

α -Farnesene

24.98

2.62

Total

-

83.45

Total unknown

-

16.55

 

Table II. Effect of bay leaves extract (BLE) on lipid profile, liver function, heart function, TNF-α and interleukin-6 in high cholesterol diet (HCD) induced hypercholesteraemic rats.

Parameters

C

BLE

HCD

HCD & BLE

TC (mg/dl)

146.18±6.92c

140.73±6.43c

285.46±7.62a

192.27±6.37b

TG (mg/dl)

109.45±5.83c

102.54±5.12c

207.32±5.71a

146.34±4.92b

HDL-C (mg/dl)

41.58±2.64a

43.92±2.45a

30.68 ±1.29c

37.83±1.46b

LDL-C (mg/dl)

82.71±4.16c

76.30±4.24c

213.32±5.68a

125.18±6.13b

vLDL-C(mg/dl)

21.89±1.48c

20.50±1.56c

41.46±1.85a

29.26±1.44b

AST (U/ml)

31.52±1.57c

30.42±1.38c

54.24±2.31a

42.58±1.73b

ALT (U/ml)

28.65±1.42c

26.47±0.92c

49.52±1.76a

37.65±0.93b

ALP(U/100ml)

6.58±0.64c

5.87±0.71c

21.23±0.81a

15.24±0.67b

γGT (U/ml)

5.12±0.48c

4.86±0.42c

13.25±0.63a

8.29±0.61b

LDH (U/ml)

229.31±16.21c

223.61±18.65c

539.43±19.27a

345.31±17.12b

CPK (U/L)

259.65±7.59c

256.71±9.82c

464.29±10.10a

308.34±9.95b

CK-MB(ng/mL)

3.15 ±0.69c

3.11±0.76c

7.29±1.22a

4.97 ±0.97b

CTnI (ng/mL)

24.63±1.57c

23.59±1.34c

62.74±2.86a

36.17±1.48b

TNF--α (pg/mL)

621.34± 24.51c

609.37 ± 21.72c

908.23±37.15a

702.43 ± 32.11b

IL-6 (pg/mL)

321.25 ± 22.41c

315.37± 21.13c

492.38±26.97a

371.21± 23.16b

 

TC, total cholesterol; TG, triglycerides; HDL-C, high-density lipoprotein-cholesterol; LDL-C, Low-density lipoprotein-cholesterol; vLDL-C, very Low-density lipoprotein-cholesterol. ALT, alanine transaminase; AST, aspartate transaminase; ALP, alkaline phosphatase; γGT, γ-glutamyl transferase; LDH, lactate dehydrogenase; CPK, creatine phosphokinase; CK-MB, creatinine kinase-MB; cTnI, cardiac troponin I; TNF-α, tumour necrotic factor-alpha; IL-6; interleukin-6. Values are expressed as means ± S.E. (n=7). Values in the same row with different superscript are significantly different at P<0.05.

 

Table III. Effect of BLE on hepatic and cardiac lipid peroxidation and antioxidant status in high cholesterol diet (HCD) induced hypercholesteraemic rats.

Parameters

C

BLE

HCD

HCD and BLE

MDA

(n mol/g tissue)

Liver

223.12±4.17c

216.42±5.20c

386.12±7.14a

259.36±6.12b

Heart

136.25±4.31c

137.42±4.51c

241.63±5.36a

172.40±4.22b

GSH

(mg/g tissue)

Liver

34.32±0.61a

36.56±0.92a

16.92±0.57c

28.91±0.92b

Heart

5.39 ± 0.26a

5.89 ± 0.25a

3.05 ± 0.21c

4.81 ± 0.24b

SOD

(U/mg protein)

Liver

45.71±1.23a

47.35±1.17a

26.35±1.30c

39.21±1.19b

Heart

28.57±1.34a

29.32±1.28a

17.24±1.16c

21.96±1.19b

CAT

(U/mg protein)

Liver

49.83±1.61a

50.91±1.72a

31.76±1.52c

44.15±1.35b

Heart

42.95±1.35a

44.18±1.30a

21.62±1.23c

35.29±1.27b

 

MDA, malondialdehyde; GSH, glutathione; SOD, superoxide dismutase; CAT, Catalase. Values are expressed as means ± S.E. (n=7). Values in the same row with different superscript are significantly different at P<0.05.

 

Discussion

Feeding high-cholesterol diet (HCD) on a long term is one of risk factors that can cause arteriosclerosis, thrombosis and infarction (Csonka et al., 2016). Bay leaves represent a good source of bioactive components that help to elevate the total antioxidant status and protect against lipid peroxidation induced by oxidative stress (Casamassima et al., 2017).

The results of essential oil composition revealed that bay leaf possesses a lot of effective volatile oils that characterized by their antioxidant properties such as 1.8-cineole, Linalool and sabinene. These results agree with the results of Da Silveira et al. (2014) and Flamini et al. (2007). The composition of the essential oil is highly affected by genotype of the plant species, seasonality, and geographic and weather conditions (Da Silveira et al., 2014).

The obtained results revealed that there is a significant increase in lipid profile in HCD- group compared to control group. Li et al. (2011) concluded that long-lasting high-fat diet leads to lipid metabolism disturbance and hyper-lipidemia by reducing lipid metabolic enzymes such as hepatic lipase and lipoprotein lipase. The study of Fungwe et al. (1994) demonstrated that severe hypercholesterolemia resulted in inhibition of rate-limiting enzyme in cholesterol catabolism cholesterol 7a-hydroxylase, enhancement of hepatic TG synthesis and the reduction of fatty acid beta-oxidation. The increased serum levels of LDL-C and vLDL-C in this study indicate that more cholesterol and triglyceride are being transported from the liver to the extra-hepatic tissues to be taken up by those tissues (Adekunle et al., 2013). Additionally, feeding HCD found to increase the level of LDL-C which could be attributed to the ability of cholesterol and saturated fatty acids included in the diet to induce down regulation in LDL receptors (Mustad et al., 1997). The elevation of LDL-C, total cholesterol, triglycerides, and reduction of HDL can lead to the development and progression of atherosclerosis (Adams, 2005).

Also, the results showed that HCD induced over production of free fatty acids into blood stream resulted in excessive release of pro-inflammatory adipocytokines such as IL-6 and TNFα (Soto-Vaca et al., 2013) with marked elevation in the level of hepatic and cardiac MDA and reduction of GSH content and the activity of antioxidant enzymes (SOD and CAT) when compared with control group. The inflammation and oxidation induced by feeding HCD can cause cellular damage, loss of functional integrity, and/ or permeability of cell membrane that can induce the leakage of LDH, CPK, AST, ALT (Dikshit et al., 1995) and CK-MB into the plasma (Mitani et al., 2003). The release of these enzymes from the damaged hepatic or myocardial membranes indicates hypercholesterolemia-induced hepatic and myocardial necrosis (Fouad, 2020).

A significant reduction in the group of rats integrated with HCD and BLE has been observed in the level of lipid contents, enzymatic parameters of liver and heart function, Ro-inflammatory factors (IL-6 and TNF-α) and MDA. While a marked elevation in the same group has been observed in the level of HDL-C, GSH content and the activity of antioxidant enzymes (SOD and CAT) when compared with the hypercholesterolemic group. The results agreed with Casamassima et al. (2016) who showed the bay leaf recovering lipid profile in hyperlipidaemic rabbits. Asadi-Samani et al. (2014) reported that medicinal plants such as bay leaf may reduce hyperlipidaemia, supress atherosclerosis and vascular endothelium damage. The effect of BLE could be attributed to its content of essential oil, flavonoids and phenolic compounds that induced improvements in insulin sensitivity which would lead to improvements in the level of glucose and blood lipids (Al-Samarrai et al., 2017). Aljamal (2010) suggested that there is a positive effect of bay leaves consumption in preventing atherosclerosis by increasing the level of HDL that can prevent the accumulation of lipid peroxides on LD. Gasparyan et al. (2015) found that injection of ethanol extract of dried bay leaves in carbon tetrachloride-mice improved liver function by reducing the level of ALT, AST, ALP and gamma-GT. The antioxidant effect of BLE could be related to Bay leaves’ scavenger activity of essential oil and its main components that can reduce superoxide and hydroxyl radicals (Basak and Candan, 2013). In addition, Casamassima et al. (2016) indicated that the antioxidant activity of bay leaves could be attributed to the ability of its phenol compounds to act as donors of hydrogen, metal chelators and radical scavenger of peroxides and superoxides.

Conclusion

The results of present research underline that the treatment of hypercholesterolemia with bay leaf leaves extract is highly effective in lowering hyperlipidaemia. Also, the results obtain that BLE has high potential effect in improving liver function and preventing atherosclerosis and controlling the oxidative status. The effective role of BLE could be attributed to the presence of several type of essential oil (1.8-cineole, Linalool and sabinene) that have been identified in this study by using Gas chromatography instrument.

Statement of conflict of interest

The authors have declared no conflict of interest.

References

Adams, L.B., 2005. Guidelines for adolescent nutrition services. Division of Epidemiology and Community Health School of Public Health, University of Minnesota.

Adams, R.P., 1995. Identification of essential oil components by gas chromatography/mass spectroscopy. Allured publishing Gorol stream Illinois, USA 310.

Adekunle, A.S., Adedeji, A.L., Oyewo, E.O., Adedosu, O.T. and Omotoso, A.T., 2013. Hyperlipidemia induced by atherogenic diet enhanced oxidative stress in the kidney and inflammatory responses: An in vivo study. Asian J. Nat. appl. Sci., 2: 82-93.

Aljamal, A., 2010. Effects of bay leaves on blood glucose and lipid profiles on the patients with type 1 diabetes. World Acad. Sci. Eng. Technol., 4: 194–197.

Allain, C.C., Poon, L.S., Chan, C.S., Richmond, W., and Fu, P.C., 1974. Enzymatic determination of total serum cholesterol. Clin. Chem., 20: 470. https://doi.org/10.1093/clinchem/20.4.470

Al-Samarrai, O.R., Naji, N.A., and Hameed, R.R., 2017. Effect of Bay leaf (Laurus nobilis L.) and its isolated (flavonoids and glycosides) on the lipids profile in the local Iraqi female rabbits. Tikrit J. Pure Sci., 22: 72-75.

Asadi-Samani, M., Bahmani, M., and Rafieian-Kopaei, M., 2014. The chemical composition, botanical characteristic and biological activities of Borago officinalis: A review. Asian Pac. J. trop. Med., 7: S22-S28. https://doi.org/10.1016/S1995-7645(14)60199-1

Basak, S.S., and Candan, F., 2013. Effect of Laurus nobilis L. essential oil and its main components on a-glucosidase and reactive oxygen species scavenging activity. Iran. J. Pharm. Sci., 12: 367–379.

Beutler, E., Duron, O., and Kelly, B.M., 1963. Improved method for the determination of blood glutathione. J. Lab. clin. Med., 61: 882-888.

Casamassima, D., Chiosi, F., Vizzarri, F., Palazzo, M. and Costagliola, C., 2017. The effect of laurus nobilis on the blood and lenses antioxidant activity in rabbit under fat-enriched diet. Physiol. Res., 66: 325-333. https://doi.org/10.33549/physiolres.933409

Casamassima, D., Palazzo, M., Vizzarri, F., Coppola, R., Costagliola, C., Corino, C., and Costanzo, A.D., 2016. Dietary effect of dried bay leaves (Laurus nobilis) meal on some biochemical parameters and on plasma oxidative status in New Zealand white growing rabbit. J. Anim. Physiol. Anim. Nutr., 2016: 1-10. https://doi.org/10.1111/jpn.12584

Csonka, C., Sárközy, M., Pipicz, M., Dux, L., and Csont, T., 2016. Modulation of hypercholesterolemia-induced oxidative/nitrative stress in the heart. Oxid. Med. Cell. Longev., 2016: 23. https://doi.org/10.1155/2016/3863726

Da Silveira, S.M., Luciano, F.B., Fronza, N.J.A.C., Scheuermann, G.N., and Vieira, C.R.W., 2014. Chemical composition and antibacterial activity of Laurus nobilis essential oil towards foodborne pathogens and its application in fresh Tuscan sausage stored at 7 °C. LWT Fd. Sci. Technol., 59: 86-93. https://doi.org/10.1016/j.lwt.2014.05.032

Demacker, P.N., Vos-Janssen, H.E., Hifmans, A.G.M., Van’tLaar, A. and Jansen, A.P., 1980. Measurement of high- density lipoprotein cholesterol in serum: Comparison of six isolation methods combined with enzymatic cholesterol analysis. Clin. Chem., 26: 1780. https://doi.org/10.1093/clinchem/26.13.1780

Dikshit, M., Rastogi, L., Shukla, R. and Srimal, R.C., 1995. Prevention of ischaemia-induced biochemical changes by curcumin and quinidine in the cat heart. Indian J. med. Res. 101: 31–35.

FlaminiG., Tebano M., Cionia P.L., Ceccarini L., Ricci, A.S. and Longo, I., 2007. Comparison between the conventional method of extraction of essential oil of Laurus nobilis L. and a novel method which uses microwaves applied in situ, without resorting to an oven. J. Chromatogr. A, 1143: 36-40. https://doi.org/10.1016/j.chroma.2007.01.031

Fossati, P., and Prencipe, L., 1982. Serum triglycerides determined calorimetrically with an enzyme that produce hydrogen peroxide. Clin. Chem., 28: 2077. https://doi.org/10.1093/clinchem/28.10.2077

Fouad, G.I., 2020. Synergistic anti-atherosclerotic role of combined treatment of omega-3 and co-enzyme Q10 in hypercholesterolemia-induced obese rats. Heliyon, 6: e03659. https://doi.org/10.1016/j.heliyon.2020.e03659

Friedwald, W.T., Levy, R.I., and Fredrickson, D., 1972. Estimation of concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin. Chem., 18: 499. https://doi.org/10.1093/clinchem/18.6.499

Fungwe, T.V., Fox, J.E., Cagen, L.M., Wilcox, H.G. and Heimberg, M., 1994. Stimulation of fatty acid biosynthesis by dietary cholesterol and of cholesterol synthesis by dietary fatty acid. J. Lipid Res., 35: 311-318. https://doi.org/10.1016/S0022-2275(20)41220-9

Gasparyan, G., Tiratsuyan, S., Kazaryan, S., and Vardapetyan, H., 2015. Effect of Laurus nobilis extract on the functioning of liver against CCl4 induced toxicity. J. exp. Biol. agric. Sci., 3: 174–218.

Hartanti, L., Yonas, S.M.K., Mustamu, J.J., Wijaya, S., Setiawan, H.K. and Soegianto, L., 2019. Influence of extraction methods of bay leaves (Syzygium polyanthum) on antioxidant and HMG-CoA reductase inhibitory activity. Heliyon, 5: e01485. https://doi.org/10.1016/j.heliyon.2019.e01485

Inoue, Y., Goto, H., Horinuki, R., Kimura, Y. and Toda, T., 1990. Experimental atherosclerosis in the rat carotid artery induced by balloon de-endothelialization and hyperlipidemia. J. Jpn. Atheroscler. Soc., 18: 1147–1154. https://doi.org/10.5551/jat1973.18.12_1147

Johansson, L.H. and Borg, L.A.H., 1988. A spectrophotometric method for determination of catalase activity in small tissue samples. Anal. Biochem., 74: 331. https://doi.org/10.1016/0003-2697(88)90554-4

Kind, P. and King, E., 1954. Estimation of plasma phosphatase by determination of hydrolysed phenol with aminoantipyrine. J. clin. Pathol., 7: 322. https://doi.org/10.1136/jcp.7.4.322

King, J.,1965. The dehydrogenases or oxidoreductases lactate dehydrogenase. In: Practical Clinical Enzymology. Van Nostrand Company Ltd, London, pp. 83-93.

Li, C., Xin-Bo, M., Yu-Hong, L., Shi-Cheng, P., Yi-Ping, F. and Min, W., 2011. Effects of persimmon leaf total flavonoid on enzyme of lipoprotein metabolism and antioxidation in hyperlipidemia rats. Chin. J. nat. Med., 9: 74. https://doi.org/10.1016/S1875-5364(11)60024-1

Makkos, A., Szántai, Á., Pálóczi, J., Pipis, J., Kiss, B., Poggi, P., Ferdinandy, P., Chatgilialoglu, A. and Görbe, A., 2020. A comorbidity model of myocardial ischemia/reperfusion injury and hypercholesterolemia in rat cardiac myocyte cultures. Front. Physiol., 10: 1564. https://doi.org/10.3389/fphys.2019.01564

Minami, M. and Yoshikawa, H., 1979. A simplified assay method of superoxide dismutase activity for clinical use. Clin. Chim. Acta, 92: 337-342. https://doi.org/10.1016/0009-8981(79)90211-0

Mitani, H., Egashira, K. and Kimura, M., 2003. HMG-CoA reductase inhibitor, fluvastatin, has cholesterol-lowering independent ‘direct’ effects on atherosclerotic vessels in high cholesterol diet-fed rabbits. Pharmacol. Res., 48: 417-427. https://doi.org/10.1016/S1043-6618(03)00184-1

Mohammed, R.R., Omer, A.K., Yener, Z., Uyar, A. and Ahmed, A.K., 2021. Biomedical effects of Laurus nobilis L. leaf extract on vital organs in streptozotocin-induced diabetic rats: Experimental research. Annls Med. Surg., 61: 188–197. https://doi.org/10.1016/j.amsu.2020.11.051

Mustad, V.A., Etherton, T.D., Cooper, A.D., Mastro, A.M., Pearson, T.A., Jonnalagadda, S.S., and Kris-Etherton, P.M., 1997. Reducing saturated fat intake is associated with increased levels of LDL-receptors on mononuclear cells in healthy men and women. J. Lipid Res., 38: 459- 468. https://doi.org/10.1016/S0022-2275(20)37254-0

Pluijmert, N.J., den Haan, M.C., van Zuylen, V.L., Steendijk, P., de Boer, H.C., van Zonneveld, A.J., Fibbe, W.E., Schalij, M.J., Quax, P.H.A. and Atsma, D.E., 2019. Hypercholesterolemia affects cardiac function, infarct size and inflammation in APOE*3- Leiden mice following myocardial ischemiareperfusion injury. PLoS One, 14: e0217582. https://doi.org/10.1371/journal.pone.0217582

Reitman, S. and Frankel, S., 1957. A calorimetric method for the determination of serum glutamic oxalacetic and glutamic pyruvic transaminases. Am. J. clin. Pathol., 28: 56. https://doi.org/10.1093/ajcp/28.1.56

Rosalki, S.B., 1975. Gamma glutamyl transpeptidase. Adv. clin. Chem., 17: 53–107. https://doi.org/10.1016/S0065-2423(08)60248-6

Soto-Vaca, A., Losso, J.N., McDonough, K. and Finley, J.W., 2013. Differential effect of 14 free fatty acids in the expression of inflammation markers on human arterial coronary cells. J. Agric. Fd. Chem., 61: 6110074-6110079. https://doi.org/10.1021/jf402966r

Yao, Y.S., Li, T.D. and Zeng, Z.H., 2020. Mechanisms underlying direct actions of hyperlipidemia on myocardium: An updated review. Lipids Hlth. Dis., 19: 23. https://doi.org/10.1186/s12944-019-1171-8

Yoshioka, T., Kawada, K., Shimada, T. and Mori, M., 1979. Lipid peroxidation in maternal and cord blood and protective mechanism against activated-oxygen toxicity in the blood. Am. J. Obstet. Gynecol., 135: 372-376. https://doi.org/10.1016/0002-9378(79)90708-7

To share on other social networks, click on any share button. What are these?

Pakistan Journal of Zoology

October

Pakistan J. Zool., Vol. 56, Iss. 5, pp. 2001-2500

Featuring

Click here for more

Subscribe Today

Receive free updates on new articles, opportunities and benefits


Subscribe Unsubscribe